Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
626
Total Claims
$461K
Drug Cost
36
Beneficiaries
$13K
Cost/Patient
Risk Score Breakdown 38/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+661%
Opioid rate vs peers
47.8% vs 6.3% avg
-6%
Cost per patient vs peers
$13K vs $14K avg
+22%
Brand preference vs peers
17.9% vs 14.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 661% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
47.8%
Opioid Rate
299
Opioid Claims
$16K
Opioid Cost
27.1%
Long-Acting Rate
This provider's opioid prescribing rate of 47.8% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 112 claims · $306K
Generic: 514 claims · $155K
Patient Profile
47
Avg Age
47%
Female
5.15
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About